Literature DB >> 9973542

Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.

M Tuchman1, M Yudkoff.   

Abstract

Plasma levels of glutamine (456 determinations), alanine (434 determinations), and asparagine (431 determinations) and corresponding ammonia levels (260 determinations) were retrospectively analyzed in 30 patients with hyperammonemia secondary to urea cycle disorders (including 3 patients with amino acid transport defects) and 5 patients with propionic acidemia (PA). All patients had elevated glutamine levels on one or more testing except for 2 patients with severe PA and 1 patient with a mild urea cycle disorder. All but 4 patients with urea cycle disorders showed a maximal glutamine level higher than 100 micromol/dl, and 3 patients had a maximal glutamine level of higher than 200 micromol/dl. The only exceptions were 2 asymptomatic ornithine transcarbamylase (OTC)-deficient females, 1 male with mild OTC deficiency, and 1 patient with citrullinemia (CIT) whose plasma glutamine levels were never above 100 micromol/L. Patients with CIT and argininosuccinic aciduria (ASA) showed statistically significant lower levels of glutamine than patients with other urea cycle disorders. However, the maximal glutamine level did not directly correlate with severity of the disorder and within disorders correlated inversely with severity of outcome. Patients with PA showed statistically significant lower glutamine, alanine, and asparagine levels than patients with urea cycle disorders and the severity of this disorder correlated inversely with plasma glutamine levels. Plasma ammonia levels showed a positive correlation with glutamine in patients with carbamyl phosphate synthetase I and OTC deficiency and a negative correlation in patients with PA. Although, most patients also showed elevated levels of alanine and asparagine, their levels generally did not show a good correlation with glutamine (R2 = 0.25 and 0.34, respectively). Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973542     DOI: 10.1006/mgme.1998.2783

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Inter-relations between 3-hydroxypropionate and propionate metabolism in rat liver: relevance to disorders of propionyl-CoA metabolism.

Authors:  Kirkland A Wilson; Yong Han; Miaoqi Zhang; Jeremy P Hess; Kimberly A Chapman; Gary W Cline; Gregory P Tochtrop; Henri Brunengraber; Guo-Fang Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-20       Impact factor: 4.310

2.  Anaplerotic therapy in propionic acidemia.

Authors:  Nicola Longo; Leisa B Price; Eduard Gappmaier; Nancy L Cantor; Sharon L Ernst; Carrie Bailey; Marzia Pasquali
Journal:  Mol Genet Metab       Date:  2017-07-12       Impact factor: 4.797

3.  Plasma glutamine and ammonia concentrations in ornithine carbamoyltransferase deficiency and citrullinaemia.

Authors:  C J Wilson; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

4.  Coma query cause.

Authors:  Georgina Elizabeth Wood; James McNicholas
Journal:  BMJ Case Rep       Date:  2015-05-06

Review 5.  Clinical practice: the management of hyperammonemia.

Authors:  Johannes Häberle
Journal:  Eur J Pediatr       Date:  2010-12-17       Impact factor: 3.183

Review 6.  Amino acid metabolism in patients with propionic acidaemia.

Authors:  Sabine Scholl-Bürgi; Jörn Oliver Sass; Johannes Zschocke; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2010-11-27       Impact factor: 4.982

Review 7.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 8.  Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.

Authors:  A Cartagena; A N Prasad; C A Rupar; M Strong; M Tuchman; N Ah Mew; C Prasad
Journal:  Can J Neurol Sci       Date:  2013-01       Impact factor: 2.104

9.  Cross-sectional multicenter study of patients with urea cycle disorders in the United States.

Authors:  Mendel Tuchman; Brendan Lee; Uta Lichter-Konecki; Marshall L Summar; Marc Yudkoff; Stephen D Cederbaum; Douglas S Kerr; George A Diaz; Margaretta R Seashore; Hye-Seung Lee; Robert J McCarter; Jeffrey P Krischer; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2008-06-17       Impact factor: 4.797

10.  Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.

Authors:  Adam J Guenzel; Sean E Hofherr; Matthew Hillestad; Mary Barry; Eric Weaver; Sarah Venezia; Jan P Kraus; Dietrich Matern; Michael A Barry
Journal:  Mol Ther       Date:  2013-05-07       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.